Gewählte Publikation:
MAASS, G; SCHWEIGHOFFER, T; BERGER, M; SCHMIDT, W; HERBST, E; ZATLOUKAL, K; BUSCHLE, M.
Tumor vaccines: effects and fate of IL-2 transfected murine melanoma cells in vivo.
Int J Immunopharmacol. 1995; 17(2):65-73
Doi: 10.1016/0192-0561(94)00085-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
-
Zatloukal Kurt
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- We have previously demonstrated the general usefulness of the adenovirus-enhanced transferrinfection (AVET) in the generation of IL-2 producing tumor vaccines. By optimizing different parameters of the transfection protocol we were able to transform the poorly immunogenic M-3 mouse melanoma cell line into a potent immunogen. A long-lasting immunity was demonstrated after administration of the IL-2 releasing vaccine, since immunized animals successfully rejected native M-3 melanoma cells even after a period of more than 6 months. We also demonstrated that in vivo administration of such a vaccine is safe since transmission of the transfected IL-2 gene in host organs was not detected. IL-2 production ceased 2 days after injection because the engineered cells were destroyed. However, RT-PCR analysis of the site of vaccine injection suggests that IL-2 exerts its effects not only directly but also by inducing a set of other immunomodulator cytokines in situ that are probably indispensable in inducing a host response. We conclude that AVET of IL-2 into tumor cells is a safe and efficient method for the generation of tumor vaccines.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adenoviridae - genetics
-
Animals - genetics
-
Female - genetics
-
Interleukin-2 - biosynthesis
-
Male - biosynthesis
-
Melanoma, Experimental - genetics
-
Mice - genetics
-
Mice, Inbred DBA - genetics
-
Time Factors - genetics
-
Transfection - methods
-
Tumor Cells, Cultured - methods
-
Vaccination - methods
-
Vaccines, Attenuated - pharmacology
- Find related publications in this database (Keywords)
-
TUMOR VACCINE
-
M-3 MURINE MELANOMA MODEL
-
INTERLEUKIN-2
-
ADENOVIRUS-ENHANCED TRANSFERRINFECTION